Three negatives and a positive: problems with coronavirus tests in China
By Brenda Goh WUHAN, China (Reuters) – Trader He Ximing in the Chinese city of Wuhan says he...
Read More
FDA / Research
Covid-19: VA Study Points to Increased Mortality with Hydroxychloroquine
Standard supportive care bested either HC alone or combined with azithromycin The much-touted...
Read More
Updated Special Considerations for Heart Failure Patients: Covid-19
Clyde W. Yancy, MD, praises response of colleagues but gives voice to exhaustion Updated on...
Read More
‘A disaster’: Roche CEO’s verdict on some COVID-19 antibody tests
By John Miller ZURICH (Reuters) – Some blood tests being marketed to tell people if they...
Read MoreLabCorp to expand availability of antibody tests for COVID-19
(Reuters) – Laboratory and drug development services provider LabCorp said on Wednesday it would expand the availability of its antibody tests for the new coronavirus to more hospitals and healthcare organizations starting...
Read More
It’ll be months before coronavirus vaccine is ready: German minister
BERLIN (Reuters) – Health Minister Jens Spahn said on Wednesday that it would take months to...
Read More
Covid-19: FDA Authorizes First At-Home Test Kit
Test kits should be on the market within weeks WASHINGTON — The FDA authorized the first...
Read More
Recovered, almost: China’s early patients unable to shed coronavirus
By Brenda Goh WUHAN, China (Reuters) – Dressed in a hazmat suit, two masks and a face...
Read MoreFDA authorizes at-home sample collection for LabCorp’s COVID-19 test
By Saumya Joseph (Reuters) – The U.S. Food and Drug Administration authorized at-home sample collection for LabCorp’s COVID-19 diagnostic kit, the agency said on Tuesday, allowing patients to send in their nasal swab...
Read More
Coronavirus very likely of animal origin, no sign of lab manipulation: WHO
GENEVA (Reuters) – The World Health Organization (WHO) said on Tuesday that all available...
Read More
WHO warns lifting of coronavirus lockdowns must be gradual
BEIJING (Reuters) – The World Health Organization warned on Tuesday that any lifting of...
Read More
Los Angeles coronavirus infections 40 times greater than known cases, antibody tests suggest
By Dan Whitcomb LOS ANGELES (Reuters) – Some 4.1% of adults tested positive for coronavirus...
Read MoreGrifols says anti-coronavirus hyperimmune immunoglobins may be ready mid-July
BARCELONA (Reuters) – Spanish pharmaceutical company Grifols said on Tuesday the hyperimmune immunoglobins it is developing as a treatment against SARS-COV-2 could be ready in mid-July. The Barcelona-based company also...
Read More
Covid-19: Novartis Launches RCT of Hydroxychloroquine
The three-arm, placebo-controlled, phase III trial will take place at more than a dozen U.S. sites...
Read More
Covid-19: Hand Sanitizer Poisonings Spike
Since early March, calls to poison centers about exposures to cleaning and disinfectant chemicals...
Read More
Covid-19: Did It Come from Bats, a Lab Accident, a Bioweapons Experiment?
Let’s look at the evidence. Was the emergence of the novel coronavirus SARS-CoV-2 a natural event,...
Read More
Novartis to test efficacy of old malaria drug against COVID-19
By John Miller and Michael Erman ZURICH/NEW YORK (Reuters) – Swiss drugmaker Novartis AG...
Read MoreAlexion to study rare blood-disorder drug in severe COVID-19 patients
(Reuters) – Alexion Pharmaceuticals Inc said on Monday it would start a late-stage study of its rare blood-disorder drug, Ultomiris, in COVID-19 patients hospitalized with severe pneumonia or acute respiratory distress...
Read MoreIDEXX Labs launches COVID-19 test for pets amid rare cases of human-to-pet transmission
(Reuters) – IDEXX Laboratories Inc said on Monday it would provide veterinarians a COVID-19 test for pets amid evidence that infected humans could transmit the virus to their pets. The company advised that veterinarians...
Read MoreUK to trial use of COVID-19 survivors’ blood plasma for treatment
LONDON (Reuters) – The United Kingdom is preparing to collect the blood from COVID-19 survivors to investigate if convalescent plasma transfusions could improve an infected patient’s speed of recovery and chances of...
Read More